Breaking
The Insightful Investing
Author

admin

Browsing
Sport

California state track meet makes changes after Trump’s objections

Sport 5 Mins Read

There could be two winners in some girls events this weekend at the California state high school track and field meet − a transgender athlete and a cisgender athlete.

The scenario is part of rule changes made after President Donald Trump demanded a transgender athlete not be allowed to compete in girls track and field events.

The California Interscholastic Federation (CIF), the state’s governing body for high school athletics, clarified the new rules in a press release May 28.

A new division will not be created to separate transgender athletes from cisgender athletes. But athletes assigned female at birth will receive medals based on where they would have finished if a transgender athlete had not competed in the same event − part of what the CIF is calling a ‘pilot entry process.”

Governor Gavin Newsom’s spokesman, Izzy Gardon, in a statement provided to USA TODAY Sports, said, “CIF’s proposed pilot is a reasonable, respectful way to navigate a complex issue without compromising competitive fairness. The Governor is encouraged by this thoughtful approach.”

AB Hernandez, a 16-year-old transgender athlete, won titles in the triple jump and long jump at the southern California regional championship last weekend and is scheduled to compete in those events and the high jump in girls’ varsity.

On May 27, Trump threatened to withhold federal funds from California if the state does not follow an executive order seeking to bar transgender athletes from women’s sports. His post on social media referred to a trans athlete who competes in girls track and field.

Later in the day, the CIF changed the rules for the championship, which will be held May 30-31 in Clovis.

‘The CIF values all of our student-athletes and we will continue to uphold our mission of providing students with the opportunity to belong, connect, and compete while complying with California law and Education Code,” the federation said in a statement. ‘With this in mind, the CIF will be implementing a pilot entry process for the 2025 CIF State Track and Field Championships.

As part of the changes, additional female athletes were invited to compete in the 2025 state championships.

Medals at the state meet

Hernandez, a top contender in the girls triple jump and long jump, could end up standing on the medal podium next to the athlete who finishes second in the overall standings. Both would receive a first-place medal.

A duplicate medal would be created to accomodate the two athletes.

Hernandez would receive a medal based on her finish in the overall standings while the other athletes will receive medals based on their finish in the standings excluding Hernandez’s results.

The CIF awards nine medals to the top boys and girls finishers in each event. (By contrast, other states create up to five divisions for each event to accomodate the athletes representing schools with a wide range of enrollments.)

Hernandez also is expected to contend for a medal in the high jump.

Also, as part of the rule changes, the CIF said in a statement that it would invite ‘any biological female student-athlete who would have earned the next qualifying mark’ to compete in the state championships.

“Under this pilot entry process, any biological female student-athlete who would have earned the next qualifying mark for one of their Section’s automatic qualifying entries in the CIF State meet, and did not achieve the CIF State at-large mark in the finals at their Section meet, was extended an opportunity to participate in the 2025 CIF State Track and Field Championships,” the CIF said in a statement. “The CIF believes this pilot entry process achieves the participation opportunities we seek to afford our student-athletes.”

The CIF did not say how many athletes that could impact.

Trump’s post on social media

Although the CIF did not cite Trump, the rule changes took place hours after his social media post that in part read, ‘THIS IS NOT FAIR, AND TOTALLY DEMEANING TO WOMEN AND GIRLS.’

Trump isn’t the only one who has sounded off on the matter. So has Hernandez.

 “I’m still a child, you’re an adult, and for you to act like a child shows how you are as a person,’’ she told Capital & Main in a story published May 15.

Certain things remain unknown. Such as how many female athletes will be impacted by the new rules and whether they’ll be applied only in events in which Hernandez is competing.

The CIF did immediately respond to requests for information submitted by USA TODAY Sports.

In March, Newsom said on his podcast that it is ‘deeply unfair’ to allow transgender girls and women to compete in women’s sports.

California law prohibits discrimination based on gender identity, including at schools. State law also allows trans student athletes to compete on sports teams that align with their gender identity.

Last month Democratic state lawmakers blocked two bills that would have banned transgender athletes from girls sports.

This post appeared first on USA TODAY

Keep Reading
Stock

The Best Five Sectors, #20

Stock 5 Mins Read

Technology Back in Top-5

Last week’s market decline of 2-2.5% (depending on the index) has led to some notable shifts in sector performance and rankings.

This pullback, coming after a strong rally, is changing the order of highs and lows on the weekly chart — a particularly significant development, at least for me.

Let’s dive into the details and see what’s flying around in the market.

The composition of the top five sectors has seen some notable changes. Here’s how it stands now:

The big surprise here is Technology making its way into the top five, displacing Consumer Staples (now at #6). This shift suggests a gradual move from a more defensive positioning to sectors that are more cyclical and economically sensitive.

Another eye-catching move comes from Consumer Discretionary, jumping from #10 to #7 — a significant leap, albeit still in the bottom half of the ranking. Real Estate and Materials saw minor shifts, while Energy dropped to #10 and Health Care remains at #11.

  1. (1) Industrials – (XLI)
  2. (4) Communication Services – (XLC)*
  3. (3) Utilities – (XLU)
  4. (2) Financials – (XLF)*
  5. (6) Technology – (XLK)*
  6. (5) Consumer Staples – (XLP)*
  7. (10) Consumer Discretionary – (XLY)*
  8. (7) Real-Estate – (XLRE)*
  9. (8) Materials – (XLB)*
  10. (9) Energy – (XLE)*
  11. (11) Healthcare – (XLV)

Weekly/Daily RRG Analysis

The weekly Relative Rotation Graph (RRG) provides some interesting insights:

  • Utilities maintains very high readings, but Consumer Staples (highest on RS-Ratio ranking) is likely to be pushed down by weak daily chart readings.
  • Industrials continues to push further into the leading quadrant with stable momentum.
  • Financials and Communication Services are inside the weakening quadrant but have room to curl back towards leading.
  • Technology, despite having the second-lowest RS-Ratio reading, is rapidly improving with a strong RS-Momentum heading over recent weeks.

Remember, the ranking combines daily and weekly readings.

Technology’s high daily chart reading is propelling it into the top five, while Consumer Staples’ weak daily reading is pushing it out.

Industrials: The Leader Holding Strong

XLI is now pushing against its all-time high, just below 145. After two weeks of attempts, last week’s slight market decline confirms that this resistance level has worked.

We’re now looking for where any potential decline might stop and form a new low. The gap area from two weeks ago seems to be a good support area to watch.

The relative strength line breaking out of its consolidation formation continues to drag the RRG lines higher. XLI, for good reason, remains the strongest sector at the moment.

Communication Services: Stable Relative Uptrend

XLC is continuing its move higher with remarkable stability. The uptrend in the RS line is still valid, currently testing the lower boundary of the rising channel.

Due to the lack of upward relative momentum in recent weeks, both RRG lines are now pointing lower.

However, the RS-Ratio line remains well above 100, keeping the XLC tail on the right-hand side of the RRG.

Utilities: Testing Resistance

XLU is pushing against overhead resistance but has yet to manage a decisive break higher.

With defensive sectors under pressure, it’s questionable whether this breakout will happen in the short term.

The RS line versus SPY is dropping back into its trading range, unable to break away decisively. This drop is causing the RS-Momentum line to roll over and start pointing lower.

It’s the recent strength in relative strength that’s keeping Utilities inside the leading quadrant for now.

Financials: At a Crossroads

The Financial sector seems to be respecting the old rising support line as resistance, with the market dropping off that line last week and now trading around $50.

This move is affecting the relative strength line, which has returned to the lower boundary of the rising channel — a level that needs to hold to maintain a positive outlook for XLF.

The RS-Ratio line is stable around 102.50, high enough to keep Financials on the right-hand side of the graph.

The RS-Momentum line has just dropped below 100, positioning the XLF tail inside the weakening quadrant, but with enough room to curl back up before hitting lagging.

Technology: The Week’s Winner

XLK saw a significant jump two weeks ago and has since returned to test the old resistance area as support. If last week’s decline continues, there’s a bit more room to the downside — $220 seems to be a good level to watch for support, marking the bottom of the gap range from two weeks ago.

The jump has pushed the relative strength line above its falling resistance line, a good sign that seems to be breaking the relative downtrend in place since mid-last year.

This is changing the characteristics of the relative strength move for the Technology sector.

For now, it has only pushed the RS-Momentum line above 100, moving XLK into the improving quadrant on the weekly RRG, but it’s already starting to drag the RS-Ratio line higher.

Portfolio Performance

We’re clawing back some of the losses from recent weeks. The underperformance of almost 6% last week has now shrunk to 4.6%. Still behind the benchmark, but closing in again and narrowing the gap.

It’s a long-term game, so we keep pushing forward. So far, nothing out of the ordinary. Let’s wait and see whether we’ve seen the low in underperformance and how long it will take to return to SPY’s performance since inception.

#StayAlert –Julius

Keep Reading
Stock

Larry Williams on the Fed, Interest Rates & Markets! What’s Next?

Stock 1 Min Read

In this must-see market update, Larry Williams returns with timely stock market analysis, trading insights, and macroeconomic forecasts. Discover what’s next for the Federal Reserve, interest rates, and inflation — and how it could impact top stocks like Tesla (TSLA), Nvidia (NVDA), Apple (AAPL), and consumer staples (XLP).

This video originally premiered on May 27, 2025. Watch on StockCharts’ dedicated Larry Williams page!

Previously recorded videos from Larry are available at this link.

Keep Reading
Stock

Smarter Options Trading Starts Here! StockCharts + OptionsPlay

Stock 1 Min Read

In this video, Chip Anderson, President of StockCharts, sits down with Tony for a conversation in the StockCharts studio! During this in-depth Q&A session, Chip and Tony explore the powerful features that make the OptionsPlay add-on a must-have for options traders using the StockCharts platform. They discuss the integration of the StockCharts Scanning Engine with OptionsPlay strategies—showcasing how this tool enhances your ability to find trade setups quickly and effectively.

This video premiered on May 23, 2025.

Keep Reading
Stock

Mixed Signals on the Charts? RRG Reveals Market Rotation Tension

Stock 1 Min Read

Confused by mixed market signals? Follow along as Julius analyzes sector rotation, asset rotation, and global market trends using daily and weekly Relative Rotation Graphs (RRGs).

In this video, Julius puts the current sector rotation in perspective on both weekly and daily Relative Rotation Graphs (RRGs). He also examines asset rotation and the position of the U.S. markets in relation to international equities.

This video was originally published on May 27, 2025. Click on the icon above to view on our dedicated page for Julius.

Past videos from Julius can be found here.

#StayAlert, -Julius

Keep Reading
Stock

Is It A Pullback? Or is More Downside Ahead?

Stock 1 Min Read

Get the latest stock market update with Mary Ellen McGonagle. Learn key downside signals, how to manage pullbacks, and which earnings reports could impact the market next week.

In this week’s episode, Mary Ellen reviews where the markets currently stand and what to watch for to signal further downside. She also highlights ways to combat inevitable pullbacks and shares the key earnings reports that are likely to move the markets in the upcoming week.

This video originally premiered May 23, 2025. You can watch it on our dedicated page for Mary Ellen’s videos.

New videos from Mary Ellen premiere weekly on Fridays. You can view all previously recorded episodes at this link.

If you’re looking for stocks to invest in, be sure to check out the MEM Edge Report! This report gives you detailed information on the top sectors, industries and stocks so you can make informed investment decisions.

Keep Reading
Investing

Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies

Investing 4 Mins Read

Alzheimer’s disease treatment stocks are focused on Alzheimer’s disease, a degenerative brain disorder that results in declining memory and thinking skills and typically affects people in their mid-60s.

According to the Alzheimer’s Association, neurons in other areas of the brain also begin to deteriorate as Alzheimer’s disease gets worse, resulting in the loss of basic human functions and overall cognitive impairment.

This condition affects more than 7 million people in the US alone; it’s also the most common form of dementia and is the seventh leading cause of death in America. Treatments are available to alleviate Alzheimer’s disease symptoms, but there are currently none that affect the underlying causes of this neurodegenerative disease.

Alzheimer’s disease therapies that have been approved by the US Food and Drug Administration (FDA) include: rivastigmine by Novartis (NYSE:NVS); galantamine, developed by Janssen, a division of Johnson & Johnson (NYSE:JNJ); donepezil by Pfizer (NYSE:PFE); and memantine by AbbVie (NYSE:ABBV).

Since there is no cure for Alzheimer’s disease, death is often the result for patients as the ailment causes brain deterioration. And unfortunately, Alzheimer’s disease is rising in prevalence — a report from Grand View Research suggests that the global Alzheimer’s disease treatment market will be worth a significant US$15.57 billion by 2030 as more patients need treatment, and as more investments are made in biomarkers for diagnosis and drug development.

1. Biogen (NASDAQ:BIIB)

Market cap: US$18.43 billion
Share price: US$125.81

The first NASDAQ-listed Alzheimer’s drug company on this list is Massachusetts-based Biogen, a pioneer in the field of neuroscience. The firm is focused on developing, manufacturing and marketing therapies aimed at treating serious neurological, neurodegenerative, autoimmune and rare diseases.

The global biotechnology firm’s research areas include Alzheimer’s disease and dementia. However, the launch of Biogen’s FDA-approved Alzheimer’s disease drug Aduhelm faced a lot of pushback in 2022, both from the market and from Congress, over what was viewed as a hasty fast-track approval process and exorbitant costs to patients.

Biogen gave it another go with Leqembi (lecanemab-irmb), its amyloid-beta monoclonal antibody for the treatment of Alzheimer’s disease, which the FDA approved in 2023 under its accelerated approval pathway. The drug was jointly developed by Biogen and Tokyo-based pharmaceutical company Eisai (OTC Pink:ESALF,TSE:4523). It is for patients with mild cognitive impairment or mild dementia, and is the first drug shown to slow the progression of Alzheimer’s disease to win FDA approval.

In January 2025, Leqembi received another FDA approval, this time for intravenous maintenance dosing for early-stage Alzheimer’s. Later, in April, the European Commission granted Leqembi Marketing Authorization in the EU for the treatment of mild early-stage Alzheimer’s disease.

That same month, the FDA granted fast track designation to Biogen’s investigational tau-targeting therapy BIIB080 for the treatment of Alzheimer’s.

Biogen’s earnings report for Q1 shows that first quarter global in-market sales of Leqembi reached approximately US$96 million, including US in-market sales of approximately US$52 million.

2. Acadia Pharmaceuticals (NASDAQ:ACAD)

Market cap: US$3.68 billion
Share price: US$21.98

Acadia Pharmaceuticals specializes in neuroscience and neuro-rare diseases. The biotech’s product portfolio includes the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis, as well as the first and only approved drug in the United States and Canada for the treatment of Rett syndrome.

Acadia’s clinical-stage pipeline includes drug candidates targeting Prader-Willi syndrome and Alzheimer’s disease psychosis.

The company expects to enroll its final patient in its RADIANT Phase 2 study of ACP-204 in Alzheimer’s disease psychosis by early 2026 and release topline data in mid-2026.

According to the company, there are currently no approved treatments for hallucinations and delusions associated with Alzheimer’s disease psychosis.

3. Anavex Life Sciences (NASDAQ:AVXL)

Market cap: US$642.85 million
Share price: US$7.53

Anavex Life Sciences is a clinical-stage biopharmaceutical company developing treatments for neurodegenerative, neurodevelopmental and neuropsychiatric disorders, such as Alzheimer’s disease, Parkinson’s disease, schizophrenia, Rett syndrome and other central nervous system disorders.

Anavex’ lead drug candidate, Anavex 2-73 (blarcamesine), has successfully completed Phase 2a and a Phase 2b/3 clinical trials for Alzheimer’s disease.

In early January, the company announced positive topline safety and efficacy data from more than three years of continuous treatment with blarcamesine for early Alzheimer’s disease patients. Later that month, Anavex announced it had been issued a US patent for the treatment.

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
Investing

Investment Protection Agreement with the Ecuador Government on Challenger’s El Guayabo Project

Investing 2 Mins Read

Challenger Gold Limited (ASX: CEL) (‘CEL’ or the ‘Company’) is pleased to announce it has entered into an Investment Protection Agreement (“IPA” or “the Agreement”) with the Government of Ecuador for its 100% owned El Guayabo Project (“El Guayabo” or “the Project”). Under the terms of the IPA, the Government of Ecuador has granted CEL legal protections including stability of the regulatory framework, resolution of disputes through international arbitration, and protection of CEL’s investment.

The IPA covers US$75 million in investment from CEL encompassing expenditures from CEL’s initial acquisition of the project in 2019 and expenditure incurred until the end of 2027. It has an initial term of 8 years and is renewable. Key incentives and protections under the IPA include:

  • Regulatory stability and protection from changes to the current legal framework
  • The legal framework at the time of execution will continue to apply if the terms are more favourable to the project owner than any potential new framework
  • The IPA guarantees rights including non-discriminatory treatment, property protection, and legal certainty
  • International arbitration, should there be any disputes in relation to the Project, with the seat of arbitration in London under the rules of the International Chamber of Commerce

Commenting on the Investment Protection Agreement, CEL Managing Director, Mr Kris Knauer, said

“The completion of the Investment Protection Agreement is a significant development for the Project..

The IPA provides certainty with respect to the legal framework governing the Project, including stable mining regulations and fiscal terms, and security of title and investment for the term of the agreement. Additionally, it provides protection from all forms of confiscation and a mechanism for international arbitration should there be any disputes related to the project.

The IPA is also timely given recent corporate action in Ecuador as we take steps to monetise our Ecuador assets following the significant resource upgrade from 4.5 million ounce1 to 9.1 million ounces1,2,3.‘

Click here for the full ASX Release

This post appeared first on investingnews.com

Keep Reading
Investing

WESTERN COPPER FORMALLY EXTENDS INVESTOR RIGHTS AGREEMENT WITH MITSUBISHI MATERIALS

Investing 4 Mins Read

 western copper and gold corporation (‘Western’ or the ‘Company’) (TSX: WRN) (NYSE American: WRN) is pleased to announce that Mitsubishi Materials Corporation (‘Mitsubishi Materials’) has completed the precondition for the previously announced extension of their investor rights agreement.

Mitsubishi Materials acquired two million common shares of the Company through open market purchases, taking their overall ownership to approximately 5%. Consequently, the investor rights agreement between the two groups has now been extended to May 30, 2026 , in accordance with the amended terms announced on April 15, 2025 .

‘We are extremely pleased to maintain, and enhance, our relationship with Mitsubishi Materials.’ said Sandeep Singh , President and CEO. ‘They remain an incredibly supportive shareholder, and we value their expertise as we advance the Casino Project.’

ABOUT western copper and gold corporation

western copper and gold corporation is developing the Casino Project, Canada’s premier copper-gold mine in the Yukon Territory and one of the most economic greenfield copper-gold mining projects in the world.

The Company is committed to working collaboratively with our First Nations and local communities to progress the Casino Project, using internationally recognized responsible mining technologies and practices.

For more information, visit www.westerncopperandgold.com .

On behalf of the board,

‘Sandeep Singh’

Sandeep Singh
President and CEO
western copper and gold corporation

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain ‘forward-looking information’ and ‘forward-looking statements’ (collectively ‘forward-looking statements’) within the meaning of applicable Canadian and United States securities legislation including the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date of this news release. Forward-looking statements are frequently, but not always, identified by words such as ‘expects’, ‘anticipates’, ‘believes’, ‘plans’, ‘projects’, ‘intends’, ‘estimates’, ‘envisages’, ‘potential’, ‘possible’, ‘strategy’, ‘goals’, ‘opportunities’, ‘objectives’, or variations thereof or stating that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘might’ or ‘will’ be taken, occur or be achieved, or the negative of any of these terms and similar expressions. Such forward-looking statements herein include statements regarding the anticipated advancement of the Casino Project, the continued support and involvement of Mitsubishi Materials, and the potential benefits of the extended investor rights agreement.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual events to be materially different from those expressed or implied by such statements. Such factors include but are not limited to the risk of unforeseen challenges in advancing the Casino project, potential impacts on operational continuity, changes in general market conditions that could affect the Company’s performance; and other risks and uncertainties disclosed in the Company’s annual information form and Form 40-F for the most recently completed financial year and its other publicly filed disclosure documents.

Forward-looking statements are based on assumptions management believes to be reasonable, such assumptions and factors as set out herein, and in the Company’s annual information form and Form 40-F for the most recently completed financial year and its other publicly filed disclosure document.

Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, other factors may cause results to be materially different from those anticipated, described, estimated, assessed or intended. These forward-looking statements represent the Company’s views as of the date of this news release. There can be no assurance that any forward-looking statements will be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not intend to and does not assume any obligation to update forward-looking statements other than as required by applicable law.

View original content to download multimedia: https://www.prnewswire.com/news-releases/western-copper-formally-extends-investor-rights-agreement-with-mitsubishi-materials-302466858.html

SOURCE western copper and gold corporation

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/28/c7490.html

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading